How [14C]-DSP-5336 is Absorbed, Broken Down, and Removed From the Body After a Single Oral Dose in Patients With Advanced Blood Cancers
Clinical trial NCT07444268 · RECRUITING
Trial details
- NCT number
- NCT07444268
- Sponsor
- Sumitomo Pharma America, Inc.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-26
- Primary completion
- 2026-08-01
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.